Core Viewpoint - Rentokil Initial plc is facing legal action due to alleged misleading statements regarding its financial performance and integration challenges with Terminix, leading to significant stock price declines during the class period [1][5]. Financial Performance - In Q1 2024, Rentokil reported organic revenue growth in North America of only 1.5% year-over-year, which was below the company's guidance of 2% for the quarter and 2% to 4% for the full year [3]. - Following the Q1 results announcement, Rentokil's ADS price dropped 9%, from $28.25 on April 17, 2024, to $25.61 on April 18, 2024 [3]. - On September 11, 2024, Rentokil revised its North American organic revenue growth forecast for the second half of the year down to 1%, significantly below previous guidance [4]. - The share price fell by approximately 21% on the news of the revised forecast, from $31.60 on September 10, 2024, to $24.95 on September 11, 2024 [4]. Integration Challenges - The lawsuit claims that Rentokil faced significant disruptions and execution challenges during the integration of Terminix, which negatively impacted its business operations and revenue growth [5]. - CEO Andy Ransom acknowledged that the integration process was complex and far from complete, attributing issues to internal execution failures rather than market conditions [4]. - Analysts from UBS and Deutsche Bank expressed concerns over Rentokil's credibility and lowered profit forecasts, predicting prolonged integration challenges and slowed growth through 2026 [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Rentokil Initial plc regarding a class action lawsuit due to alleged misleading statements and execution challenges related to the integration of Terminix [1][3]. Group 1: Allegations - The complaint alleges that during the class period from December 1, 2023, to September 10, 2024, Rentokil made materially false and misleading statements [3]. - Specific allegations include disruption in early pilots of the Terminix integration, significant self-inflicted execution challenges, and the failure to integrate Terminix, which negatively impacted organic revenue growth in North America [3]. - The lawsuit claims that Rentokil and Terminix remained separate businesses and that the positive statements made by the defendants lacked a reasonable basis [3]. Group 2: Class Action Details - Shareholders who purchased shares of Rentokil during the specified class period are encouraged to register for the class action, with a deadline of January 27, 2025, to seek lead plaintiff status [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Shareholders of Rentokil Initial plc (RTO) who have incurred financial losses are encouraged to reach out to Levi & Korsinsky regarding a pending class action lawsuit [1] Group 1 - The class action is aimed at addressing the grievances of shareholders who lost money on their investments in Rentokil Initial plc [1] - Levi & Korsinsky is the law firm representing the interests of the affected shareholders [1]

Core Viewpoint - Rentokil Initial Plc stockholders are presented with an opportunity to lead a class action lawsuit against the company, indicating potential legal challenges ahead for the firm [1] Group 1 - The announcement is made by Bronstein, Gewirtz and Grossman, LLC, a law firm that specializes in securities class action lawsuits [1] - The class action lawsuit is likely a response to alleged misconduct or misrepresentation by Rentokil Initial Plc, which could impact investor confidence [1] - Stockholders are encouraged to participate in the lawsuit, suggesting a significant level of concern among investors regarding the company's practices [1]

Core Viewpoint - Investors in Rentokil Initial plc are encouraged to contact Levi & Korsinsky before January 27, 2025, to discuss their rights regarding potential claims [1] Group 1 - The deadline for investors to reach out is set for January 27, 2025 [1] - The communication is aimed at discussing rights related to potential claims against Rentokil Initial plc [1]

RTO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rentokil Initial plc Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action – RTO ...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Rentokil Initial plc Lawsuit - RTO ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating claims on behalf of investors of Rentokil, focusing on potential securities violations and the impact on shareholder value [1] Group 1: Investigation Details - The investigation aims to determine whether Rentokil and its executives misled investors regarding the company's financial health and business operations [1] - The firm is particularly interested in any statements made by Rentokil that may have been false or misleading, which could have affected the stock price [1] Group 2: Implications for Investors - Investors who purchased Rentokil securities may have been harmed by the alleged misrepresentations, leading to potential financial losses [1] - The outcome of the investigation could influence future investment decisions and the overall perception of Rentokil in the market [1]

RTO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Rentokil Initial Plc Shareholders Have Opportunity to Lead Class Action Lawsuit! ...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Rentokil Lawsuit – RTO ...